Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TBC1D24 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | SCRT1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | SLC35D3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | PTOV1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | SH2D4A | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | SEC11C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | DEF8 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | PHF10 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | RSBN1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | UCN3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |